ロード中...
Pre-Analytical and Clinical Validation of a Dried Blood Spot Assay for Asymmetric Dimethylarginine and L-Arginine
Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis. It is a risk marker for cardiovascular events and mortality in patients with cardiometabolic diseases and in population-based studies. Plasma or serum analysis of ADMA may be hampered by pre-analytical sample handling. We valid...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7230730/ https://ncbi.nlm.nih.gov/pubmed/32283799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041072 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|